2023
DOI: 10.1016/j.chest.2022.12.044
|View full text |Cite
|
Sign up to set email alerts
|

Guided Bronchoscopy for the Evaluation of Pulmonary Lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
31
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(32 citation statements)
references
References 130 publications
1
31
0
Order By: Relevance
“…The pooled diagnostic yield in our meta‐analysis is comparable to previously published studies that reported pooled diagnostic yields of 76.5%–84.3% for RAB 11,14,41 . Despite the comparable results, in previous meta‐analyses, the diagnostic yields in the included studies were defined differently.…”
Section: Discussionsupporting
confidence: 73%
See 2 more Smart Citations
“…The pooled diagnostic yield in our meta‐analysis is comparable to previously published studies that reported pooled diagnostic yields of 76.5%–84.3% for RAB 11,14,41 . Despite the comparable results, in previous meta‐analyses, the diagnostic yields in the included studies were defined differently.…”
Section: Discussionsupporting
confidence: 73%
“…The pooled diagnostic yield in our meta-analysis is comparable to previously published studies that reported pooled diagnostic yields of 76.5%-84.3% for RAB. 11,14,41 Despite the comparable results, in previous meta-analyses, the diagnostic yields in the included studies were defined differently. Instead of directly synthesizing the diagnostic yields reported in individual studies, we extracted the actual results of RAB and reconstructed the diagnostic yields according to a uniform definition.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…Despite advances in technology, a recent meta-analysis of 16,389 lesions from 126 studies using guided bronchoscopic techniques noted no significance difference in diagnostic yield prior to 2012 (70.5%) versus after 2012 (69.2%), nor significant differences between different technologies utilized. Notably this analysis had a limited number of studies included that utilized robotic assistance [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…In nodules with an intermediate risk of lung cancer (10%–65%), bronchoscopic or transthoracic biopsies are recommended to evaluate further management 4 . Recent studies, however, demonstrated that the diagnostic yield of bronchoscopic procedures is significantly lower in nodules with an intermediate risk of lung cancer (42%) compared to nodules with a high risk of malignancy (77%) 5,6 . Therefore, the need for improved bronchoscopic techniques to diagnose lung nodules is urgent, especially in nodules with an intermediate risk of lung cancer.…”
Section: Introductionmentioning
confidence: 99%